Fig. 2. Comparison of Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (Ph+ ALL) subjects with the CD34+CD38-CD58- phenotype versus other phenotypes regarding the time to complete remission (CR; in days) after induction chemotherapy.